Ternary Therapeutics
TernaryTx, a pioneering biotech startup, with a revolutionary AI-driven platform for designing molecular glue therapeutics, opening new frontiers in drug discovery for previously "undruggable" targets.
Ternary Therapeutics has raised €4.2M across 1 funding round from 4 investors, most recently a Seed round in Mar 2026. Based in London, UK; active in AI. Data as of 28 Oct 2026.
London, UKwww.ternarytx.co.uk ↗
Total raised
€4.2M
€4,167,004
Funding rounds
1
Investors
4
distinct backers
Active since
2026-03
latest 2026-03
Funding by year
EUR raised per year · 2026 YTDTernary Therapeutics — funding by year — interactive chart.
Data table
| Ternary Therapeutics — funding by year | |
|---|---|
| 2026 | €4.2M |
Signals
High confidenceRaise-next likelihood45
base rate 44% for Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-03-18 | Seed | €4.2M | Future Planet Capital,i&i Biotech Fund,Pace Ventures,UK Innovation & Science Seed Fund | View deal → |